China-based BGI Genomics must pay Illumina Inc. $8 million for infringing gene-sequencing patents, a federal jury in California said.

The Biden administration plans to tighten travel rules to combat the omicron variant of the coronavirus, by requiring all air travelers to the U.S. to be tested within a day of their departure regardless of vaccination status, according to a person familiar with the matter.

Merck & Co.’s Covid-19 pill narrowly gained a key recommendation from advisers to U.S. regulators, after a lengthy debate about the safety of the potential game-changing treatment.

A federal court in Louisiana on Tuesday blocked the Biden administration from enforcing a vaccine mandate for health-care workers nationwide—except for in 10 states that already face an injunction order.

Pfizer Inc.’s chief executive said the company has asked the U.S. to allow Covid-19 booster shots for people age 16-17, a move that would expand access to additional doses amid worry about the new omicron virus variant.

Pfizer has submitted a request to the U.S. FDA to expand the emergency use authorization of a booster dose of its Covid-19 vaccine to include 16- and 17-year-olds, CEO Albert Bourlasaid on Twitter.